CRISPR And CRISPR-Associated Genes Market, Global Outlook and Forecast 2024-2030
Report ID
48333
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
131
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the CRISPR And CRISPR-Associated Genes market, focusing on the current trends, market dynamics, and future prospects. The report explores the global CRISPR And CRISPR-Associated Genes market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of CRISPR And CRISPR-Associated Genes, challenges faced by the industry, and potential opportunities for market players.
The global CRISPR And CRISPR-Associated Genes market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The CRISPR And CRISPR-Associated Genes market presents opportunities for various stakeholders, including Biotechnology Companies, Pharmaceutical Companies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in CRISPR And CRISPR-Associated Genes market. Additionally, the growing consumer demand present avenues for market expansion.
The global CRISPR And CRISPR-Associated Genes market was valued at US$ 1305.7 million in 2023 and is projected to reach US$ 1687.6 million by 2030, at a CAGR of 3.7% during the forecast period.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Key Features:
The research report on the CRISPR And CRISPR-Associated Genes market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the CRISPR And CRISPR-Associated Genes market.
Market Overview: The report provides a comprehensive overview of the CRISPR And CRISPR-Associated Genes market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Genome Editing, Genetic Engineering), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the CRISPR And CRISPR-Associated Genes market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the CRISPR And CRISPR-Associated Genes market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the CRISPR And CRISPR-Associated Genes market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the CRISPR And CRISPR-Associated Genes market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the CRISPR And CRISPR-Associated Genes market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the CRISPR And CRISPR-Associated Genes market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for CRISPR And CRISPR-Associated Genes, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the CRISPR And CRISPR-Associated Genes market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
CRISPR And CRISPR-Associated Genes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
    Genome Editing
    Genetic Engineering
    GRNA Database/Gene Librar
    CRISPR Plasmid
    Human Stem Cells
    Genetically Modified Organisms/Crops
    Cell Line Engineering
Market segment by Application
    Biotechnology Companies
    Pharmaceutical Companies
    Academic Institutes
    Research and Development Institutes
Global CRISPR And CRISPR-Associated Genes Market Segment Percentages, By Region and Country, 2023 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Thermo Fisher Scientific
    Editas Medicine
    Caribou Biosciences
    CRISPR therapeutics
    Intellia therapeutics, Inc.
    Cellectis
    Horizon Discovery Plc
    Sigma Aldrich
    Precision Biosciences
    Genscript
    Sangamo Biosciences Inc.
    Lonza Group Limited
    Integrated DNA Technologies
    New England Biolabs
    Origene Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRISPR And CRISPR-Associated Genes, market overview.
Chapter 2: Global CRISPR And CRISPR-Associated Genes market size in revenue.
Chapter 3: Detailed analysis of CRISPR And CRISPR-Associated Genes company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRISPR And CRISPR-Associated Genes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 CRISPR And CRISPR-Associated Genes Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CRISPR And CRISPR-Associated Genes Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CRISPR And CRISPR-Associated Genes Overall Market Size
    2.1 Global CRISPR And CRISPR-Associated Genes Market Size: 2023 VS 2030
    2.2 Global CRISPR And CRISPR-Associated Genes Market Size, Prospects & Forecasts: 2019-2030
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CRISPR And CRISPR-Associated Genes Players in Global Market
    3.2 Top Global CRISPR And CRISPR-Associated Genes Companies Ranked by Revenue
    3.3 Global CRISPR And CRISPR-Associated Genes Revenue by Companies
    3.4 Top 3 and Top 5 CRISPR And CRISPR-Associated Genes Companies in Global Market, by Revenue in 2023
    3.5 Global Companies CRISPR And CRISPR-Associated Genes Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CRISPR And CRISPR-Associated Genes Players in Global Market
        3.6.1 List of Global Tier 1 CRISPR And CRISPR-Associated Genes Companies
        3.6.2 List of Global Tier 2 and Tier 3 CRISPR And CRISPR-Associated Genes Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global CRISPR And CRISPR-Associated Genes Market Size Markets, 2023 & 2030
        4.1.2 Genome Editing
        4.1.3 Genetic Engineering
        4.1.4 GRNA Database/Gene Librar
        4.1.5 CRISPR Plasmid
        4.1.6 Human Stem Cells
        4.1.7 Genetically Modified Organisms/Crops
        4.1.8 Cell Line Engineering
    4.2 By Type - Global CRISPR And CRISPR-Associated Genes Revenue & Forecasts
        4.2.1 By Type - Global CRISPR And CRISPR-Associated Genes Revenue, 2019-2024
        4.2.2 By Type - Global CRISPR And CRISPR-Associated Genes Revenue, 2025-2030
        4.2.3 By Type - Global CRISPR And CRISPR-Associated Genes Revenue Market Share, 2019-2030
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CRISPR And CRISPR-Associated Genes Market Size, 2023 & 2030
        5.1.2 Biotechnology Companies
        5.1.3 Pharmaceutical Companies
        5.1.4 Academic Institutes
        5.1.5 Research and Development Institutes
    5.2 By Application - Global CRISPR And CRISPR-Associated Genes Revenue & Forecasts
        5.2.1 By Application - Global CRISPR And CRISPR-Associated Genes Revenue, 2019-2024
        5.2.2 By Application - Global CRISPR And CRISPR-Associated Genes Revenue, 2025-2030
        5.2.3 By Application - Global CRISPR And CRISPR-Associated Genes Revenue Market Share, 2019-2030
6 Sights by Region
    6.1 By Region - Global CRISPR And CRISPR-Associated Genes Market Size, 2023 & 2030
    6.2 By Region - Global CRISPR And CRISPR-Associated Genes Revenue & Forecasts
        6.2.1 By Region - Global CRISPR And CRISPR-Associated Genes Revenue, 2019-2024
        6.2.2 By Region - Global CRISPR And CRISPR-Associated Genes Revenue, 2025-2030
        6.2.3 By Region - Global CRISPR And CRISPR-Associated Genes Revenue Market Share, 2019-2030
    6.3 North America
        6.3.1 By Country - North America CRISPR And CRISPR-Associated Genes Revenue, 2019-2030
        6.3.2 US CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.3.3 Canada CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.3.4 Mexico CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
    6.4 Europe
        6.4.1 By Country - Europe CRISPR And CRISPR-Associated Genes Revenue, 2019-2030
        6.4.2 Germany CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.4.3 France CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.4.4 U.K. CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.4.5 Italy CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.4.6 Russia CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.4.7 Nordic Countries CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.4.8 Benelux CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
    6.5 Asia
        6.5.1 By Region - Asia CRISPR And CRISPR-Associated Genes Revenue, 2019-2030
        6.5.2 China CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.5.3 Japan CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.5.4 South Korea CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.5.5 Southeast Asia CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.5.6 India CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
    6.6 South America
        6.6.1 By Country - South America CRISPR And CRISPR-Associated Genes Revenue, 2019-2030
        6.6.2 Brazil CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.6.3 Argentina CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CRISPR And CRISPR-Associated Genes Revenue, 2019-2030
        6.7.2 Turkey CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.7.3 Israel CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.7.4 Saudi Arabia CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
        6.7.5 UAE CRISPR And CRISPR-Associated Genes Market Size, 2019-2030
7 CRISPR And CRISPR-Associated Genes Companies Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Company Summary
        7.1.2 Thermo Fisher Scientific Business Overview
        7.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.1.4 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.1.5 Thermo Fisher Scientific Key News & Latest Developments
    7.2 Editas Medicine
        7.2.1 Editas Medicine Company Summary
        7.2.2 Editas Medicine Business Overview
        7.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.2.4 Editas Medicine CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.2.5 Editas Medicine Key News & Latest Developments
    7.3 Caribou Biosciences
        7.3.1 Caribou Biosciences Company Summary
        7.3.2 Caribou Biosciences Business Overview
        7.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.3.4 Caribou Biosciences CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.3.5 Caribou Biosciences Key News & Latest Developments
    7.4 CRISPR therapeutics
        7.4.1 CRISPR therapeutics Company Summary
        7.4.2 CRISPR therapeutics Business Overview
        7.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.4.4 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.4.5 CRISPR therapeutics Key News & Latest Developments
    7.5 Intellia therapeutics, Inc.
        7.5.1 Intellia therapeutics, Inc. Company Summary
        7.5.2 Intellia therapeutics, Inc. Business Overview
        7.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.5.4 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.5.5 Intellia therapeutics, Inc. Key News & Latest Developments
    7.6 Cellectis
        7.6.1 Cellectis Company Summary
        7.6.2 Cellectis Business Overview
        7.6.3 Cellectis CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.6.4 Cellectis CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.6.5 Cellectis Key News & Latest Developments
    7.7 Horizon Discovery Plc
        7.7.1 Horizon Discovery Plc Company Summary
        7.7.2 Horizon Discovery Plc Business Overview
        7.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.7.4 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.7.5 Horizon Discovery Plc Key News & Latest Developments
    7.8 Sigma Aldrich
        7.8.1 Sigma Aldrich Company Summary
        7.8.2 Sigma Aldrich Business Overview
        7.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.8.4 Sigma Aldrich CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.8.5 Sigma Aldrich Key News & Latest Developments
    7.9 Precision Biosciences
        7.9.1 Precision Biosciences Company Summary
        7.9.2 Precision Biosciences Business Overview
        7.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.9.4 Precision Biosciences CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.9.5 Precision Biosciences Key News & Latest Developments
    7.10 Genscript
        7.10.1 Genscript Company Summary
        7.10.2 Genscript Business Overview
        7.10.3 Genscript CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.10.4 Genscript CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.10.5 Genscript Key News & Latest Developments
    7.11 Sangamo Biosciences Inc.
        7.11.1 Sangamo Biosciences Inc. Company Summary
        7.11.2 Sangamo Biosciences Inc. Business Overview
        7.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.11.4 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.11.5 Sangamo Biosciences Inc. Key News & Latest Developments
    7.12 Lonza Group Limited
        7.12.1 Lonza Group Limited Company Summary
        7.12.2 Lonza Group Limited Business Overview
        7.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.12.4 Lonza Group Limited CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.12.5 Lonza Group Limited Key News & Latest Developments
    7.13 Integrated DNA Technologies
        7.13.1 Integrated DNA Technologies Company Summary
        7.13.2 Integrated DNA Technologies Business Overview
        7.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.13.4 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.13.5 Integrated DNA Technologies Key News & Latest Developments
    7.14 New England Biolabs
        7.14.1 New England Biolabs Company Summary
        7.14.2 New England Biolabs Business Overview
        7.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.14.4 New England Biolabs CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.14.5 New England Biolabs Key News & Latest Developments
    7.15 Origene Technologies
        7.15.1 Origene Technologies Company Summary
        7.15.2 Origene Technologies Business Overview
        7.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.15.4 Origene Technologies CRISPR And CRISPR-Associated Genes Revenue in Global Market (2019-2024)
        7.15.5 Origene Technologies Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us